Ángel Miranda Alonso Miguel

Title: Innovations of Ángel Miranda Alonso Miguel

Introduction

Ángel Miranda Alonso Miguel is a notable inventor based in Valencia, Spain. He has made significant contributions to the field of photodynamic therapy, particularly through his innovative methods and compounds. His work focuses on developing chemiluminescent agents that target mitochondria, which are crucial for effective cancer treatment.

Latest Patents

Ángel Miranda Alonso Miguel holds a patent for a "Method of photodynamic therapy." This invention provides mitochondria-targeted chemiluminescent agents and their application in photodynamic therapy (PDT). The patent details compounds of general formula (I), where A represents a chemiluminescent moiety, and B represents a mitotropic moiety. These compounds are particularly useful in treating deeply-sited tumors, such as glioblastoma multiforme (GBM), when used in conjunction with a photosensitizer or photosensitizer precursor. He has 1 patent to his name.

Career Highlights

Throughout his career, Ángel has worked with esteemed institutions, including Oslo University Hospital and the Spanish National Research Council (Consejo Superior de Investigaciones Científicas). His experience in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Ángel has collaborated with notable colleagues, including Georgios C Vougioukalakis and Georgios Rotas. These partnerships have enriched his research and expanded the impact of his innovations.

Conclusion

Ángel Miranda Alonso Miguel is a pioneering inventor whose work in photodynamic therapy showcases the potential of chemiluminescent agents in cancer treatment. His contributions are significant in advancing medical science and improving therapeutic options for patients.